Author: Ravi Shankar

LEI: 213800ZBKL9BHSL2K459

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (the EUWA).

Tender offer results: projected incremental effect on certain financial metrics through to 2029

OSB GROUP PLC (the Group) has today announced the results of the tender offer for its MREL-eligible £300m Senior Holdco 2028 9.5% (the 2028 securities) and £400m Senior Holdco 2030 8.875% securities (the 2030 securities and together, the Senior Holdco securities). From 1 January 2026, the Bank of England’s preferred resolution strategy for the Group changed to Transfer. As a result, the Group’s MREL requirement is equal to its minimum capital requirements, defined as the sum of Pillar 1 and Pillar 2A, and these Senior Holdco securities are no longer required to meet its current MREL requirement. The tender offer is expected to settle on 16 November 2026.

The Group received valid tenders totalling £634,434,000 in principal amount, exceeding the originally announced £500m cap. The Group has exercised its discretion to purchase all such validly tendered Senior Holdco securities without scaling and as such, will purchase £279,585,000 of the 2028 securities at 103.369% of principal amount of such 2028 securities, and £354,849,000 of the 2030 securities at 106.083% of principal amount of such 2030 securities. Following settlement, £20,415,000 of the 2028 securities and £45,151,000 of the 2030 securities will remain outstanding.

Impact on 2026

The tender offer, once settled, is expected to reduce the Group’s profit before tax for 2026 by c.£42m through a one-off charge arising from the partial derecognition of the repurchased Senior Holdco securities. This one-off charge will comprise a c.£33m charge upon repurchase of the Senior Holdco securities, including transaction costs, and a further charge relating to hedge accounting adjustments which as at 31 October 2026 amounted to c.£9m.

On a pro-forma basis, including accounting adjustments as at 31 October 2026 and the effect of taxation, it is estimated that the day-one impact of the tender offer would have reduced the Group’s first half 2026 CET1 ratio¹ and RoTE ratio¹ by c.20bps and c.1.5%, respectively. The 2026 one-off charge from partial derecognition of the repurchased Senior Holdco securities will not form part of net interest income (NII) and therefore will not impact net interest margin (NIM).

Following completion and not including the one-off charge referred to above, the tender offer is expected to deliver a total income benefit through the reduction in coupon payments, net of hedging, on the Senior Holdco securities. Assuming the repurchased securities are replaced with central bank funding at a cost of SONIA c.+20bps, total income in 2026 is expected to increase by c.£4m and NIM¹ by c.1bp.

Expected benefit in future years

On the same replacement funding assumption, the transaction is expected to provide a total income benefit of c.£28m in 2027. This assumes, for illustrative purposes, that the 2028 securities are redeemed at their first call date in September 2027².

The benefit from reduced coupon payments, net of hedging, will continue during 2028 and into 2029, assuming, for illustrative purposes only, that the 2030 securities are redeemed at their first call date in January 2029⁴, supporting earnings and capital generation over that period.

Illustrative financial projection

Securities	Total income
	Expected increase in total income resulting from the tender offer3
	2026	2027	2028	2029
	£m	£m	£m	£m
£300m Senior Holdco 2028 9.5%	2	9	–	–
£400m Senior Holdco 2030 8.875%	2	18	18	1
Total (per year)	4	28	18	1
Total (cumulative)	4	32	50	51

1. Pro-forma CET1, RoTE and NIM impacts are calculated using the first half 2026 ratios, as disclosed in the Appendix to the 2026 Interim results
2. OSB GROUP PLC retains full discretion as to whether or not it exercises its right to redeem the Senior Holdco securities on their respective first call dates
3. Estimated total income benefit is net of hedging, assumes that the repurchased Senior Holdco securities are replaced with central bank funding at a cost of SONIA +c.20bps and excludes the one-off charge referred to above. Totals may not sum due to rounding.

Enquiries:

OSB GROUP PLC, Investor Relations                                      Brunswick Group
Alexander Holcroft/Monika Ziober/Richard Treacher                   Robin Wrench/Simone Selzer

osbrelations@osb.co.uk                                                               t: 020 7404 5959

Important disclaimer

This document should be read, together with other announcements and documents published by OSB GROUP PLC (OSBG) through the Regulatory News Service.

This unaudited document, and any related presentation, webcast or discussion (including responses to questions), may contain forward-looking statements concerning OSBG’s business, strategy, plans, objectives, expectations, financial condition, performance and ESG ambitions. Statements other than statements of historical or current fact may be forward-looking statements and are often, but not always, identified by words such as “targets”, “believes”, “estimates”, “expects”, “aims”, “intends”, “will”, “may”, “anticipates”, “plans”, “forecasts”, “outlook”, “guidance”, “future”, “could” or “should”.

Forward-looking statements involve risks, uncertainties and assumptions, and actual results or events may differ materially from those expressed or implied. Relevant factors include economic and market conditions; interest rates, inflation and funding costs; borrower and counterparty credit quality; capital, liquidity and funding; competition and customer behaviour; operational resilience, technology, cyber security and financial crime; legal, regulatory, tax and accounting developments; geopolitical events; and OSBG’s ability to execute its strategy and manage these risks. For further information, refer to the principal risks and uncertainties in OSBG’s annual report (available at www.osb.co.uk/investors).

No reliance should be placed on any forward-looking statement, and no representation or assurance is given that any forecast or expectation will be achieved. The assumptions and judgements underpinning a forward-looking statement may prove to be incorrect and involve known and unknown risks, uncertainties, contingencies and other important factors, many of which are outside the control of OSBG. Forward-looking statements speak only as of their date. Any such forward-looking statements are based on the beliefs, expectations and opinions of OSBG at the date the statements are made. Except as required by applicable law or regulation, OSBG undertakes no obligation to update any forward-looking statements and OSBG hereby disclaims, any obligation or duty to update, revise or supplement them if circumstances or management’s beliefs, expectations or opinions should change. Past performance is not a guide to future performance. No representations or warranties, expressed or implied, are given by or on behalf of OSBG as to the achievement or reasonableness of any projections, estimates, targets, commitments, ambitions, prospects or returns contained herein.

Nothing in this document constitutes an offer, invitation, financial promotion, investment advice or recommendation in relation to any security or financial instrument, or is intended to be a profit forecast or estimate.

OSBG does not guarantee that third-party information included in this document is accurate, current or complete and accepts no liability for reliance on it, except to the extent liability cannot lawfully be excluded.

This document and any non-excludable liability arising from it are governed by English law.

Figures may be rounded or converted at applicable exchange rates and may therefore not sum or reconcile exactly.

This announcement is released by OSB GROUP PLC and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the EUWA (UK MAR), encompassing information relating to the matters described above. For the purposes of UK MAR and the Implementing Technical Standards, this announcement is made by Jason Elphick, Group General Counsel and Company Secretary.

Non-IFRS performance measures
Non-IFRS performance measures provide additional insight into performance and how the Board sets targets and monitors the business, but are not substitutes for IFRS measures. Definitions, reconciliations and the most directly comparable IFRS measures are set out in the Alternative performance measures section of OSBG’s annual report (available at www.osb.co.uk/investors).

LEI: 213800ZBKL9BHSL2K459

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (the EUWA).

Tender offer results: projected incremental effect on certain financial metrics through to 2029

OSB GROUP PLC (the Group) has today announced the results of the tender offer for its MREL-eligible £300m Senior Holdco 2028 9.5% (the 2028 securities) and £400m Senior Holdco 2030 8.875% securities (the 2030 securities and together, the Senior Holdco securities). From 1 January 2026, the Bank of England’s preferred resolution strategy for the Group changed to Transfer. As a result, the Group’s MREL requirement is equal to its minimum capital requirements, defined as the sum of Pillar 1 and Pillar 2A, and these Senior Holdco securities are no longer required to meet its current MREL requirement. The tender offer is expected to settle on 16 November 2026.

The Group received valid tenders totalling £634,434,000 in principal amount, exceeding the originally announced £500m cap. The Group has exercised its discretion to purchase all such validly tendered Senior Holdco securities without scaling and as such, will purchase £279,585,000 of the 2028 securities at 103.369% of principal amount of such 2028 securities, and £354,849,000 of the 2030 securities at 106.083% of principal amount of such 2030 securities. Following settlement, £20,415,000 of the 2028 securities and £45,151,000 of the 2030 securities will remain outstanding.

Impact on 2026

The tender offer, once settled, is expected to reduce the Group’s profit before tax for 2026 by c.£42m through a one-off charge arising from the partial derecognition of the repurchased Senior Holdco securities. This one-off charge will comprise a c.£33m charge upon repurchase of the Senior Holdco securities, including transaction costs, and a further charge relating to hedge accounting adjustments which as at 31 October 2026 amounted to c.£9m.

On a pro-forma basis, including accounting adjustments as at 31 October 2026 and the effect of taxation, it is estimated that the day-one impact of the tender offer would have reduced the Group’s first half 2026 CET1 ratio¹ and RoTE ratio¹ by c.20bps and c.1.5%, respectively. The 2026 one-off charge from partial derecognition of the repurchased Senior Holdco securities will not form part of net interest income (NII) and therefore will not impact net interest margin (NIM).

Following completion and not including the one-off charge referred to above, the tender offer is expected to deliver a total income benefit through the reduction in coupon payments, net of hedging, on the Senior Holdco securities. Assuming the repurchased securities are replaced with central bank funding at a cost of SONIA c.+20bps, total income in 2026 is expected to increase by c.£4m and NIM¹ by c.1bp.

Expected benefit in future years

On the same replacement funding assumption, the transaction is expected to provide a total income benefit of c.£28m in 2027. This assumes, for illustrative purposes, that the 2028 securities are redeemed at their first call date in September 2027².

The benefit from reduced coupon payments, net of hedging, will continue during 2028 and into 2029, assuming, for illustrative purposes only, that the 2030 securities are redeemed at their first call date in January 2029⁴, supporting earnings and capital generation over that period.

Illustrative financial projection

Securities	Total income
	Expected increase in total income resulting from the tender offer3
	2026	2027	2028	2029
	£m	£m	£m	£m
£300m Senior Holdco 2028 9.5%	2	9	–	–
£400m Senior Holdco 2030 8.875%	2	18	18	1
Total (per year)	4	28	18	1
Total (cumulative)	4	32	50	51

1. Pro-forma CET1, RoTE and NIM impacts are calculated using the first half 2026 ratios, as disclosed in the Appendix to the 2026 Interim results
2. OSB GROUP PLC retains full discretion as to whether or not it exercises its right to redeem the Senior Holdco securities on their respective first call dates
3. Estimated total income benefit is net of hedging, assumes that the repurchased Senior Holdco securities are replaced with central bank funding at a cost of SONIA +c.20bps and excludes the one-off charge referred to above. Totals may not sum due to rounding.

Enquiries:

OSB GROUP PLC, Investor Relations                                      Brunswick Group
Alexander Holcroft/Monika Ziober/Richard Treacher                   Robin Wrench/Simone Selzer

osbrelations@osb.co.uk                                                               t: 020 7404 5959

Important disclaimer

This document should be read, together with other announcements and documents published by OSB GROUP PLC (OSBG) through the Regulatory News Service.

This unaudited document, and any related presentation, webcast or discussion (including responses to questions), may contain forward-looking statements concerning OSBG’s business, strategy, plans, objectives, expectations, financial condition, performance and ESG ambitions. Statements other than statements of historical or current fact may be forward-looking statements and are often, but not always, identified by words such as “targets”, “believes”, “estimates”, “expects”, “aims”, “intends”, “will”, “may”, “anticipates”, “plans”, “forecasts”, “outlook”, “guidance”, “future”, “could” or “should”.

Forward-looking statements involve risks, uncertainties and assumptions, and actual results or events may differ materially from those expressed or implied. Relevant factors include economic and market conditions; interest rates, inflation and funding costs; borrower and counterparty credit quality; capital, liquidity and funding; competition and customer behaviour; operational resilience, technology, cyber security and financial crime; legal, regulatory, tax and accounting developments; geopolitical events; and OSBG’s ability to execute its strategy and manage these risks. For further information, refer to the principal risks and uncertainties in OSBG’s annual report (available at www.osb.co.uk/investors).

No reliance should be placed on any forward-looking statement, and no representation or assurance is given that any forecast or expectation will be achieved. The assumptions and judgements underpinning a forward-looking statement may prove to be incorrect and involve known and unknown risks, uncertainties, contingencies and other important factors, many of which are outside the control of OSBG. Forward-looking statements speak only as of their date. Any such forward-looking statements are based on the beliefs, expectations and opinions of OSBG at the date the statements are made. Except as required by applicable law or regulation, OSBG undertakes no obligation to update any forward-looking statements and OSBG hereby disclaims, any obligation or duty to update, revise or supplement them if circumstances or management’s beliefs, expectations or opinions should change. Past performance is not a guide to future performance. No representations or warranties, expressed or implied, are given by or on behalf of OSBG as to the achievement or reasonableness of any projections, estimates, targets, commitments, ambitions, prospects or returns contained herein.

Nothing in this document constitutes an offer, invitation, financial promotion, investment advice or recommendation in relation to any security or financial instrument, or is intended to be a profit forecast or estimate.

OSBG does not guarantee that third-party information included in this document is accurate, current or complete and accepts no liability for reliance on it, except to the extent liability cannot lawfully be excluded.

This document and any non-excludable liability arising from it are governed by English law.

Figures may be rounded or converted at applicable exchange rates and may therefore not sum or reconcile exactly.

This announcement is released by OSB GROUP PLC and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the EUWA (UK MAR), encompassing information relating to the matters described above. For the purposes of UK MAR and the Implementing Technical Standards, this announcement is made by Jason Elphick, Group General Counsel and Company Secretary.

Non-IFRS performance measures
Non-IFRS performance measures provide additional insight into performance and how the Board sets targets and monitors the business, but are not substitutes for IFRS measures. Definitions, reconciliations and the most directly comparable IFRS measures are set out in the Alternative performance measures section of OSBG’s annual report (available at www.osb.co.uk/investors).

11,654 Line-km Airborne Survey Supports Target Evaluation Beneath Kalahari Cover; Phased Program Proposed to Test Geological and Geochemical Evidence Before Drilling

TORONTO, Nov. 13, 2026 (GLOBE NEWSWIRE) — One Bullion Ltd. (“One Bullion” or the “Company”) (TSXV: OBUL), a gold exploration company holding complete ownership of three prospective exploration projects in Botswana, today announced an exploration update on its wholly owned Maitengwe Gold Project in northeastern Botswana and outlined the next proposed phase of work, following receipt of the final dataset from its 2026 high-resolution airborne geophysical survey. The Company holds the project through its wholly owned Botswana subsidiary, Premier Gold Resources (Pty) Ltd. Maitengwe comprises prospecting licenses PL 012/2018 and PL 235/2016 and has an area of approximately 58,075 hectares (580.75 km²).

“Maitengwe is now moving from a large, underexplored land position to a series of specific geological questions that we can test in the field,” said Adam Berk, Chief Executive Officer of One Bullion. “The geophysical program has given us a much clearer view of the concealed rock architecture beneath Kalahari cover. Our focus is on testing the structural positions that may matter for gold, such as contacts, bends and intersecting trends. We intend to verify the geology, establish where our sampling methods are effective and advance only the most compelling targets to trenching and RC drilling. That staged approach is designed to deploy capital carefully while building a technically credible exploration pipeline at Maitengwe.”

Highlights

• An 11,654 line-kilometer airborne magnetic-gradient and radiometric survey, flown at 50-meter line spacing in July 2026, provides an enhanced framework for geological interpretation across the two-license Maitengwe project.
• The property lies within the Archean Francistown Granite–Greenstone Complex on the southwestern margin of the Zimbabwe Craton, an established regional setting for structurally controlled gold exploration.
• Preliminary internal desktop screening has identified 32 geophysical reconnaissance work areas grouped into nine clusters, with eight areas prioritized for initial field assessment. These are interpretive work areas, not confirmed mineralized zones or approved drill targets.
• The next proposed phase prioritizes confirmation of bedrock geology, cover conditions and geochemical sampling effectiveness, followed by selective trenching or shallow subsurface sampling and staged reverse-circulation (“RC”) drilling where warranted.
• Environmental Impact Statement approval for PL 012/2018 was granted in April 2026, subject to its conditions. Approvals, land access and activity-specific requirements remain to be confirmed for each proposed field location.

Geological Setting and Exploration Rationale

Maitengwe (Fig. 1) is located between Tutume and the Zimbabwe border in northeastern Botswana. Regional geological mapping places the Maitengwe Greenstone Belt within the Francistown Granite–Greenstone Complex of the Archean Zimbabwe Craton. The regional succession includes metamorphosed volcanic and sedimentary rocks, with local mafic–ultramafic assemblages and iron-rich units, intruded by Archean granitoids. In this type of setting, shear zones, lithological contacts, fold-related structures and quartz–carbonate vein systems may be prospective for gold. The local rock types, structures and mineralization styles at individual Maitengwe targets remain to be established by direct observation and sampling. For regional context, the Company’s Vumba Project lies to the south-southeast of Maitengwe in northeastern Botswana, and both projects are situated close to the Botswana–Zimbabwe border.

Much of Maitengwe is obscured by transported Kalahari sands, which restrict conventional surface mapping and can reduce the effectiveness of near-surface geochemical methods. The principal exploration challenge is therefore to distinguish bedrock-related features from magnetic effects, primary intrusive contacts, regolith transport and possible processing artifacts, before prioritizing expenditure on drilling.

Figure 1 – Maitengwe in context to Vumba

Results of the 2026 Airborne Program

Xcalibur Smart Mapping acquired the high-resolution magnetic-gradient and radiometric survey from July 7 to July 30, 2026, using a fixed-wing platform. Campbell & Walker Geophysics provided post-processing and preliminary interpretation. One Bullion announced receipt of the final processed dataset on October 14, 2026. The Company is integrating the processed data with historical geophysical, geological, prospecting and geochemical information, subject to verification of original records and spatial control.

Initial interpretation highlights a northeast-trending lithomagnetic framework with several contrasting geophysical domains, including curved magnetic bands in the southwest, a central magnetic trend with compact sources, short lens-like features in the west-central area, an eastern zone of intersecting or discordant trends, and a separately expressed northern banded system. The Company is assessing bends, contacts, terminations and junctions as possible sites for structural investigation. These features could reflect changes in host lithology, intrusions, deformation or a combination of factors; magnetics and radiometrics do not measure gold grade and do not establish the presence of mineralization. The accompanying Figure 2 shows a filtered first-vertical-derivative magnetic product to illustrate the interpreted magnetic fabric; colored raster extent and blank areas should not be equated with legal license boundaries.

Preliminary Target Areas for Field Verification

The Company has identified 32 reconnaissance work areas in nine clusters. Eight areas have been provisionally placed in the first-pass field-assessment group. The prioritization is an internal screening exercise based on the existing geophysical products and geological hypotheses. Field confirmation and Qualified Person review are required before any area is described as drill-ready.

Reconnaissance Setting	Principal Geological Question
Southwestern curved bands and magnetic necks	Are local bends or contacts deformed, altered and supported by in-situ gold/pathfinder geochemistry, or do they reflect primary lithology?
Central and south-central compact sources	Do the margins of magnetic bodies coincide with favorable host contacts or strain zones, rather than unmineralized intrusive margins?
Eastern lens array and discordant body termination	Do intersecting trends represent a meaningful structural junction, or a younger dyke and unrelated magnetic sources?
Northern-cap banded system	Can a bend and parallel magnetic contacts be demonstrated in bedrock, and is there reproducible geological and geochemical evidence for prioritized testing?

The list is a framework for testing competing geological interpretations. Neither the number of interpreted features nor their magnetic prominence indicates a corresponding number of gold deposits.

Proposed Staged Exploration Program

Stage 1 — Validate data and assess the ground

Reconcile airborne survey grids and quality control with historical datasets and current license boundaries; conduct focused geological and structural mapping where outcrop is accessible; determine Kalahari cover thickness and the presence of residual regolith; and complete orientation geochemical sampling using appropriate soil, saprolite or bedrock media. The objective is to confirm which geophysical features are geological, whether a sampling method is representative of underlying bedrock and which locations warrant more detailed work.

Stage 2 — Selective trenching and subsurface target definition

Where the cover profile, ground conditions and applicable approvals permit, excavate short, targeted trenches or test windows across verified contacts and structural positions. The purpose is to expose and log lithology, foliation, veining, alteration and possible sulfides and to obtain spatially controlled channel samples. Where transported cover makes surface trenching or soils ineffective, the Company may instead use a suitable shallow subsurface technique to sample the weathered-bedrock interface. The Company is not announcing a blanket trenching commitment; excavation lengths and locations will follow field results and site-specific approvals.

Stage 3 — Conditional RC drilling and follow-up

Advance targets to a staged first-pass RC program only after they demonstrate a defensible combination of geology, structure and appropriately verified geochemistry, or where a tightly scoped geological scout test is justified. Initial holes are expected to focus on the shallow bedrock and interpreted structural geometry, with orientations and depths determined from field results rather than fixed from desktop maps. Follow-up RC, and potentially oriented diamond drilling, would be contingent on geological observations, assay results and the ability to test continuity. No definitive drill-hole count, meterage, mobilization date or exploration budget is being committed in this release.

Technical Objectives and Decision Criteria

The proposed work is designed to (i) identify the rock packages and structures associated with each geophysical feature; (ii) determine whether sampling beneath cover provides meaningful, repeatable gold and pathfinder results; (iii) test the orientation, width and continuity of any mineralized structures indicated by surface or shallow work; and (iv) rank, advance or discontinue targets using explicit technical criteria. Targets that resolve as barren intrusive bodies, transported geochemical responses or unsupported geophysical features will be downgraded rather than drilled solely to complete a planned meterage.

Sampling, Quality Assurance and Environmental Controls

Future field samples will be documented with suitable location, lithological and sampling information. The planned quality-assurance/quality-control program will include appropriate certified reference materials, blanks, duplicates, and custody controls. Analysis will be by independent accredited laboratories using methods suited to the relevant sample media. Details of laboratory methods, sampling intervals, quality-control performance and any material assay results will be disclosed once the work has been completed and reviewed.

Through Premier Gold Resources (Pty) Ltd., the Company received Environmental Impact Statement approval for exploration on PL012/2018 from Botswana’s Department of Environmental Protection. The approval is effective April 20, 2026 for two years, subject to applicable mitigation and monitoring requirements. That approval does not by itself authorize for all proposed activities across both Maitengwe licenses. The Company will confirm land access, environmental obligations, site-specific permits and health and safety controls before disturbing ground.

Exploration-Stage Caution

No new Maitengwe gold assay results, mineral resource estimates or mineral reserve estimates are disclosed in this news release. Interpretations of geophysical structures, geological models and priority areas remain preliminary and subject to ground verification. The presence of a magnetic feature, lithological contact or historical selective sample is not evidence of an economically mineralized deposit. The proposed program is exploratory in nature, and there can be no assurance that further work will identify mineralization of economic significance.

Regional Context and Google Earth Views

Figure A. Relative location of the Maitengwe and Vumba projects in northeastern Botswana, shown on a Google Earth base image. The yellow line marks the Botswana–Zimbabwe international boundary visible in the Google Earth view. Company overlays are provided for regional location context only and are not cadastral tenure outlines.

Figure B. Google Earth view of the Maitengwe RTP magnetic image with selected primary and secondary reconnaissance targets overlain. Red-highlighted markers identify first-pass priority targets and orange-highlighted markers identify secondary follow-up targets. Target labels summarize the geological question being tested at each location. This figure is interpretive and does not represent a drill collar plan or verified cadastral mapping.

These Google Earth figures are included to show the relationship of Maitengwe to the Company’s Vumba Project and to illustrate how the interpreted target inventory is distributed across the Maitengwe magnetic dataset. They complement, and do not replace, the processed geophysical figures and enlarged target examples set out below.

Selected Figures — Maitengwe 2026 Exploration

Figure 2. Maitengwe 2026 airborne magnetic survey — filtered first vertical derivative of reduced-to-pole magnetics with a 15 m upward-continuation filter (RTP UP15 1VD). Original processed map supplied by Campbell & Walker Geophysics. Colored areas show the extent of the displayed processed product, not verified legal license boundaries; the irregular map edges and white interior gap do not independently establish the limits of survey acquisition or tenure. Magnetic features do not, on their own, establish gold mineralization.

Project-Wide Geophysical Reconnaissance

Figure 3. Preliminary reconnaissance areas plotted on reduced-to-pole magnetic imagery (interpretive raster, not cadastral license mapping). Red points indicate eight priority areas for initial field assessment; amber and blue points represent additional work areas. Colored circles are schematic reconnaissance envelopes, not mineralized extents, drilling approvals or surveyed collar locations. Target ranking is provisional and subject to validation by fieldwork and the Qualified Person.

Examples of Interpreted Structural Tests

Figure 4. Selected enlarged first-vertical-derivative magnetic imagery: (A) the western termination of an ENE-trending magnetic source near T19; and (B) a bend within the northern-cap magnetic system near T23. Both are conceptual geological investigation areas. Magnetic responses may reflect primary lithology, intrusive contacts, remanent magnetization or deformation; the presence of gold mineralization has not been established.

Qualified Person

The scientific and technical information in this news release has been reviewed and approved by Tim Raymond, Pr.Sci.Nat., a Qualified Person as defined under National Instrument 43-101 – Standards of Disclosure for Mineral Projects (NI 43-101). Mr Raymond provides independent geological consulting services to the Company through RAYMEX (Pty) Ltd and has conducted site visits to the Vumba Gold Project.

About One Bullion

One Bullion Ltd. (TSXV: OBUL) is a Toronto-based gold exploration company focused on advancing high-quality gold assets in Botswana, one of Africa’s stable and established mining jurisdictions. Established in 2018, the Company controls approximately 8,004 km² of prospective land across three greenstone belt-hosted gold projects, including Vumba, Kraaipan and Maitengwe. One Bullion’s strategy centers on disciplined, data-driven exploration combining modern geological methods with advanced targeting to identify and test high-priority gold targets while maintaining a commitment to environmental stewardship, community engagement and long-term value creation for stakeholders.

Forward-Looking Information

This news release contains forward-looking information and forward-looking statements within the meaning of applicable Canadian securities laws. Forward-looking information includes, without limitation, statements regarding geological interpretations, the prospectivity of Maitengwe, the scope, sequence, timing and possible methods of fieldwork, sampling, trenching, shallow subsurface investigations and drilling; intended target ranking and technical objectives; future permitting and access; and potential future exploration results. Such statements are based on management’s current assumptions and expectations, including access to funds, equipment, contractors, laboratories and required approvals, and are subject to risks and uncertainties. Actual outcomes may differ materially because of adverse geological results, ineffective sampling media, inaccessible or restricted locations, permitting requirements, contractor or laboratory delays, costs, financing conditions, changes in priorities or other operational and market factors. There can be no assurance that proposed exploration will proceed as contemplated or discover mineralization of economic significance. Readers should not place undue reliance on forward-looking information. Except as required by law, the Company undertakes no obligation to update such information.

Contact Information:
Adam Berk, Chief Executive Officer
OneBullion@KCSA.com

Investor Contact:
KCSA Strategic Communications
Jack Perkins or Valter Pinto
T: 212-896-1254
OneBullion@KCSA.com

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Photos accompanying this announcement are available at 

https://www.globenewswire.com/NewsRoom/AttachmentNg/24caaee2-f637-4444-8222-f4144df1a1e1

https://www.globenewswire.com/NewsRoom/AttachmentNg/01b5c9c3-e871-45f6-b9af-bbaeeb5cb21d

https://www.globenewswire.com/NewsRoom/AttachmentNg/3fd44d78-705b-498b-a93a-0d73606ee703

https://www.globenewswire.com/NewsRoom/AttachmentNg/9208c8f7-48ec-499c-be0c-fa2eaa71d2ca

https://www.globenewswire.com/NewsRoom/AttachmentNg/585e1624-688e-4db7-8fda-8b2f94749a65

https://www.globenewswire.com/NewsRoom/AttachmentNg/baae66aa-1233-4d33-87d3-f4a261e5ddfa

11,654 Line-km Airborne Survey Supports Target Evaluation Beneath Kalahari Cover; Phased Program Proposed to Test Geological and Geochemical Evidence Before Drilling

TORONTO, Nov. 13, 2026 (GLOBE NEWSWIRE) — One Bullion Ltd. (“One Bullion” or the “Company”) (TSXV: OBUL), a gold exploration company holding complete ownership of three prospective exploration projects in Botswana, today announced an exploration update on its wholly owned Maitengwe Gold Project in northeastern Botswana and outlined the next proposed phase of work, following receipt of the final dataset from its 2026 high-resolution airborne geophysical survey. The Company holds the project through its wholly owned Botswana subsidiary, Premier Gold Resources (Pty) Ltd. Maitengwe comprises prospecting licenses PL 012/2018 and PL 235/2016 and has an area of approximately 58,075 hectares (580.75 km²).

“Maitengwe is now moving from a large, underexplored land position to a series of specific geological questions that we can test in the field,” said Adam Berk, Chief Executive Officer of One Bullion. “The geophysical program has given us a much clearer view of the concealed rock architecture beneath Kalahari cover. Our focus is on testing the structural positions that may matter for gold, such as contacts, bends and intersecting trends. We intend to verify the geology, establish where our sampling methods are effective and advance only the most compelling targets to trenching and RC drilling. That staged approach is designed to deploy capital carefully while building a technically credible exploration pipeline at Maitengwe.”

Highlights

• An 11,654 line-kilometer airborne magnetic-gradient and radiometric survey, flown at 50-meter line spacing in July 2026, provides an enhanced framework for geological interpretation across the two-license Maitengwe project.
• The property lies within the Archean Francistown Granite–Greenstone Complex on the southwestern margin of the Zimbabwe Craton, an established regional setting for structurally controlled gold exploration.
• Preliminary internal desktop screening has identified 32 geophysical reconnaissance work areas grouped into nine clusters, with eight areas prioritized for initial field assessment. These are interpretive work areas, not confirmed mineralized zones or approved drill targets.
• The next proposed phase prioritizes confirmation of bedrock geology, cover conditions and geochemical sampling effectiveness, followed by selective trenching or shallow subsurface sampling and staged reverse-circulation (“RC”) drilling where warranted.
• Environmental Impact Statement approval for PL 012/2018 was granted in April 2026, subject to its conditions. Approvals, land access and activity-specific requirements remain to be confirmed for each proposed field location.

Geological Setting and Exploration Rationale

Maitengwe (Fig. 1) is located between Tutume and the Zimbabwe border in northeastern Botswana. Regional geological mapping places the Maitengwe Greenstone Belt within the Francistown Granite–Greenstone Complex of the Archean Zimbabwe Craton. The regional succession includes metamorphosed volcanic and sedimentary rocks, with local mafic–ultramafic assemblages and iron-rich units, intruded by Archean granitoids. In this type of setting, shear zones, lithological contacts, fold-related structures and quartz–carbonate vein systems may be prospective for gold. The local rock types, structures and mineralization styles at individual Maitengwe targets remain to be established by direct observation and sampling. For regional context, the Company’s Vumba Project lies to the south-southeast of Maitengwe in northeastern Botswana, and both projects are situated close to the Botswana–Zimbabwe border.

Much of Maitengwe is obscured by transported Kalahari sands, which restrict conventional surface mapping and can reduce the effectiveness of near-surface geochemical methods. The principal exploration challenge is therefore to distinguish bedrock-related features from magnetic effects, primary intrusive contacts, regolith transport and possible processing artifacts, before prioritizing expenditure on drilling.

Figure 1 – Maitengwe in context to Vumba

Results of the 2026 Airborne Program

Xcalibur Smart Mapping acquired the high-resolution magnetic-gradient and radiometric survey from July 7 to July 30, 2026, using a fixed-wing platform. Campbell & Walker Geophysics provided post-processing and preliminary interpretation. One Bullion announced receipt of the final processed dataset on October 14, 2026. The Company is integrating the processed data with historical geophysical, geological, prospecting and geochemical information, subject to verification of original records and spatial control.

Initial interpretation highlights a northeast-trending lithomagnetic framework with several contrasting geophysical domains, including curved magnetic bands in the southwest, a central magnetic trend with compact sources, short lens-like features in the west-central area, an eastern zone of intersecting or discordant trends, and a separately expressed northern banded system. The Company is assessing bends, contacts, terminations and junctions as possible sites for structural investigation. These features could reflect changes in host lithology, intrusions, deformation or a combination of factors; magnetics and radiometrics do not measure gold grade and do not establish the presence of mineralization. The accompanying Figure 2 shows a filtered first-vertical-derivative magnetic product to illustrate the interpreted magnetic fabric; colored raster extent and blank areas should not be equated with legal license boundaries.

Preliminary Target Areas for Field Verification

The Company has identified 32 reconnaissance work areas in nine clusters. Eight areas have been provisionally placed in the first-pass field-assessment group. The prioritization is an internal screening exercise based on the existing geophysical products and geological hypotheses. Field confirmation and Qualified Person review are required before any area is described as drill-ready.

Reconnaissance Setting	Principal Geological Question
Southwestern curved bands and magnetic necks	Are local bends or contacts deformed, altered and supported by in-situ gold/pathfinder geochemistry, or do they reflect primary lithology?
Central and south-central compact sources	Do the margins of magnetic bodies coincide with favorable host contacts or strain zones, rather than unmineralized intrusive margins?
Eastern lens array and discordant body termination	Do intersecting trends represent a meaningful structural junction, or a younger dyke and unrelated magnetic sources?
Northern-cap banded system	Can a bend and parallel magnetic contacts be demonstrated in bedrock, and is there reproducible geological and geochemical evidence for prioritized testing?

The list is a framework for testing competing geological interpretations. Neither the number of interpreted features nor their magnetic prominence indicates a corresponding number of gold deposits.

Proposed Staged Exploration Program

Stage 1 — Validate data and assess the ground

Reconcile airborne survey grids and quality control with historical datasets and current license boundaries; conduct focused geological and structural mapping where outcrop is accessible; determine Kalahari cover thickness and the presence of residual regolith; and complete orientation geochemical sampling using appropriate soil, saprolite or bedrock media. The objective is to confirm which geophysical features are geological, whether a sampling method is representative of underlying bedrock and which locations warrant more detailed work.

Stage 2 — Selective trenching and subsurface target definition

Where the cover profile, ground conditions and applicable approvals permit, excavate short, targeted trenches or test windows across verified contacts and structural positions. The purpose is to expose and log lithology, foliation, veining, alteration and possible sulfides and to obtain spatially controlled channel samples. Where transported cover makes surface trenching or soils ineffective, the Company may instead use a suitable shallow subsurface technique to sample the weathered-bedrock interface. The Company is not announcing a blanket trenching commitment; excavation lengths and locations will follow field results and site-specific approvals.

Stage 3 — Conditional RC drilling and follow-up

Advance targets to a staged first-pass RC program only after they demonstrate a defensible combination of geology, structure and appropriately verified geochemistry, or where a tightly scoped geological scout test is justified. Initial holes are expected to focus on the shallow bedrock and interpreted structural geometry, with orientations and depths determined from field results rather than fixed from desktop maps. Follow-up RC, and potentially oriented diamond drilling, would be contingent on geological observations, assay results and the ability to test continuity. No definitive drill-hole count, meterage, mobilization date or exploration budget is being committed in this release.

Technical Objectives and Decision Criteria

The proposed work is designed to (i) identify the rock packages and structures associated with each geophysical feature; (ii) determine whether sampling beneath cover provides meaningful, repeatable gold and pathfinder results; (iii) test the orientation, width and continuity of any mineralized structures indicated by surface or shallow work; and (iv) rank, advance or discontinue targets using explicit technical criteria. Targets that resolve as barren intrusive bodies, transported geochemical responses or unsupported geophysical features will be downgraded rather than drilled solely to complete a planned meterage.

Sampling, Quality Assurance and Environmental Controls

Future field samples will be documented with suitable location, lithological and sampling information. The planned quality-assurance/quality-control program will include appropriate certified reference materials, blanks, duplicates, and custody controls. Analysis will be by independent accredited laboratories using methods suited to the relevant sample media. Details of laboratory methods, sampling intervals, quality-control performance and any material assay results will be disclosed once the work has been completed and reviewed.

Through Premier Gold Resources (Pty) Ltd., the Company received Environmental Impact Statement approval for exploration on PL012/2018 from Botswana’s Department of Environmental Protection. The approval is effective April 20, 2026 for two years, subject to applicable mitigation and monitoring requirements. That approval does not by itself authorize for all proposed activities across both Maitengwe licenses. The Company will confirm land access, environmental obligations, site-specific permits and health and safety controls before disturbing ground.

Exploration-Stage Caution

No new Maitengwe gold assay results, mineral resource estimates or mineral reserve estimates are disclosed in this news release. Interpretations of geophysical structures, geological models and priority areas remain preliminary and subject to ground verification. The presence of a magnetic feature, lithological contact or historical selective sample is not evidence of an economically mineralized deposit. The proposed program is exploratory in nature, and there can be no assurance that further work will identify mineralization of economic significance.

Regional Context and Google Earth Views

Figure A. Relative location of the Maitengwe and Vumba projects in northeastern Botswana, shown on a Google Earth base image. The yellow line marks the Botswana–Zimbabwe international boundary visible in the Google Earth view. Company overlays are provided for regional location context only and are not cadastral tenure outlines.

Figure B. Google Earth view of the Maitengwe RTP magnetic image with selected primary and secondary reconnaissance targets overlain. Red-highlighted markers identify first-pass priority targets and orange-highlighted markers identify secondary follow-up targets. Target labels summarize the geological question being tested at each location. This figure is interpretive and does not represent a drill collar plan or verified cadastral mapping.

These Google Earth figures are included to show the relationship of Maitengwe to the Company’s Vumba Project and to illustrate how the interpreted target inventory is distributed across the Maitengwe magnetic dataset. They complement, and do not replace, the processed geophysical figures and enlarged target examples set out below.

Selected Figures — Maitengwe 2026 Exploration

Figure 2. Maitengwe 2026 airborne magnetic survey — filtered first vertical derivative of reduced-to-pole magnetics with a 15 m upward-continuation filter (RTP UP15 1VD). Original processed map supplied by Campbell & Walker Geophysics. Colored areas show the extent of the displayed processed product, not verified legal license boundaries; the irregular map edges and white interior gap do not independently establish the limits of survey acquisition or tenure. Magnetic features do not, on their own, establish gold mineralization.

Project-Wide Geophysical Reconnaissance

Figure 3. Preliminary reconnaissance areas plotted on reduced-to-pole magnetic imagery (interpretive raster, not cadastral license mapping). Red points indicate eight priority areas for initial field assessment; amber and blue points represent additional work areas. Colored circles are schematic reconnaissance envelopes, not mineralized extents, drilling approvals or surveyed collar locations. Target ranking is provisional and subject to validation by fieldwork and the Qualified Person.

Examples of Interpreted Structural Tests

Figure 4. Selected enlarged first-vertical-derivative magnetic imagery: (A) the western termination of an ENE-trending magnetic source near T19; and (B) a bend within the northern-cap magnetic system near T23. Both are conceptual geological investigation areas. Magnetic responses may reflect primary lithology, intrusive contacts, remanent magnetization or deformation; the presence of gold mineralization has not been established.

Qualified Person

The scientific and technical information in this news release has been reviewed and approved by Tim Raymond, Pr.Sci.Nat., a Qualified Person as defined under National Instrument 43-101 – Standards of Disclosure for Mineral Projects (NI 43-101). Mr Raymond provides independent geological consulting services to the Company through RAYMEX (Pty) Ltd and has conducted site visits to the Vumba Gold Project.

About One Bullion

One Bullion Ltd. (TSXV: OBUL) is a Toronto-based gold exploration company focused on advancing high-quality gold assets in Botswana, one of Africa’s stable and established mining jurisdictions. Established in 2018, the Company controls approximately 8,004 km² of prospective land across three greenstone belt-hosted gold projects, including Vumba, Kraaipan and Maitengwe. One Bullion’s strategy centers on disciplined, data-driven exploration combining modern geological methods with advanced targeting to identify and test high-priority gold targets while maintaining a commitment to environmental stewardship, community engagement and long-term value creation for stakeholders.

Forward-Looking Information

This news release contains forward-looking information and forward-looking statements within the meaning of applicable Canadian securities laws. Forward-looking information includes, without limitation, statements regarding geological interpretations, the prospectivity of Maitengwe, the scope, sequence, timing and possible methods of fieldwork, sampling, trenching, shallow subsurface investigations and drilling; intended target ranking and technical objectives; future permitting and access; and potential future exploration results. Such statements are based on management’s current assumptions and expectations, including access to funds, equipment, contractors, laboratories and required approvals, and are subject to risks and uncertainties. Actual outcomes may differ materially because of adverse geological results, ineffective sampling media, inaccessible or restricted locations, permitting requirements, contractor or laboratory delays, costs, financing conditions, changes in priorities or other operational and market factors. There can be no assurance that proposed exploration will proceed as contemplated or discover mineralization of economic significance. Readers should not place undue reliance on forward-looking information. Except as required by law, the Company undertakes no obligation to update such information.

Contact Information:
Adam Berk, Chief Executive Officer
OneBullion@KCSA.com

Investor Contact:
KCSA Strategic Communications
Jack Perkins or Valter Pinto
T: 212-896-1254
OneBullion@KCSA.com

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Photos accompanying this announcement are available at 

https://www.globenewswire.com/NewsRoom/AttachmentNg/24caaee2-f637-4444-8222-f4144df1a1e1

https://www.globenewswire.com/NewsRoom/AttachmentNg/01b5c9c3-e871-45f6-b9af-bbaeeb5cb21d

https://www.globenewswire.com/NewsRoom/AttachmentNg/3fd44d78-705b-498b-a93a-0d73606ee703

https://www.globenewswire.com/NewsRoom/AttachmentNg/9208c8f7-48ec-499c-be0c-fa2eaa71d2ca

https://www.globenewswire.com/NewsRoom/AttachmentNg/585e1624-688e-4db7-8fda-8b2f94749a65

https://www.globenewswire.com/NewsRoom/AttachmentNg/baae66aa-1233-4d33-87d3-f4a261e5ddfa

Medical Segment Revenue Grows 136% Year-Over-Year

Expands CompuFlo® Physician Partnerships and Advances Medical Commercialization

Online Demonstrations More Than Double Reflecting Increased Customer Engagement

Reaffirms 2026 Outlook for Double-Digit Revenue Growth, Including Significant Growth in CompuFlo® Sales

Identifies approximately $400,000 in Additional Annual Savings, Supporting Expectation to Approach or Achieve Profitability in Fourth Quarter 2026 and Additional Profitable Quarters in 2027

ROSELAND, N.J., Nov. 13, 2026 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the three and nine months ended September 30, 2026.

Recent Business Highlights

• Identified cost-reduction initiatives expected to generate approximately $400,000 in additional annual savings, strengthening the Company’s path to potential profitability in Q4 2026 and additional profitable quarters in 2027.
• Expanded CompuFlo® clinical adoption across major healthcare organizations, highlighted by the initiation of clinical use at Rothman Orthopaedics, a nationally recognized orthopedic organization, and the addition of Pain and Spine Specialists, a 22-location Northeastern U.S. pain management network, and its medical director, Dr. Sudhir Rao, to the CompuFlo Advisor Program.
• Built a pipeline of more than 500 U.S. commercial leads, supported by five dedicated medical sales professionals, approximately 15 sales consultants and three distribution partners, with federal market access through Red One Medical.
• Reinforced CompuFlo’s clinical value proposition through a peer-reviewed 79-patient University of Texas Medical Branch study associating CompuFlo-guided epidural access with approximately 91% lower adjusted odds of composite complications compared with conventional loss-of-resistance techniques during spinal cord stimulator implantation.
• Highlighted substantial market potential across an estimated 30 million-plus annual epidural procedures worldwide, including more than 11 million in the U.S. Just 2% U.S. penetration could represent approximately $33 million in annual disposable revenue at $150 per procedure (illustrative only; not a revenue forecast).
• Submitted a provisional patent application for a potential new application of CompuFlo technology in intrathecal pump refills, extending its potential beyond epidural procedures.
• Strengthened international medical commercialization through distributor engagement and market development activities in Italy and Greece to support CompuFlo adoption and recurring sales.
• Pursued global strategic partnerships through go-to-market and licensing discussions with major medical technology organizations to expand international market reach.
• Broadened dental distribution opportunities through engagement with four potential distribution channels collectively serving thousands of dental offices.
• Achieved a debt-free balance sheet by eliminating outstanding director loans through a debt-to-equity conversion, supporting the Company’s focus on financial discipline.

“During the third quarter, we continued to advance our commercial strategy while maintaining disciplined expense management,” said Eric Hines, Chief Executive Officer of Milestone Scientific. “As anticipated, revenue moderated following the second quarter, which benefited from two large international orders. At the same time, we continued to build our commercial pipeline, with completed online demonstrations more than doubling during the first nine months of the year compared with the prior-year period. We believe this reflects growing customer engagement and the continued development of a more scalable sales process that can support future growth across our business. In dental, we are making progress with four potential distribution channels serving thousands of offices.

“In our medical business, we are gaining traction with major healthcare organizations, highlighted by the initiation of clinical use at Rothman Orthopaedics, a nationally recognized orthopedic organization with 34 locations, and the addition of Pain and Spine Specialists, a 22-location pain management network, to our CompuFlo® Advisor Program. These developments represent important milestones in expanding institutional engagement and physician adoption. We continue to strengthen reimbursement access, commercial infrastructure and clinical support to accelerate utilization and recurring disposable revenue with more than 500 U.S. commercial leads, our priority is converting that pipeline into active accounts and increasing procedure volumes. Internationally, we are seeing growing momentum in medical, and we are pursuing go-to-market and licensing initiatives with a few large medical technology organizations.

“Looking ahead, we expect to approach profitability, or be profitable, in the fourth quarter of 2026. Our team has remained focused on identifying cost-saving opportunities across the business, with initiatives expected to generate approximately $400,000 in additional annual savings, further strengthening our path to profitability. For 2027, we expect considerably lower losses than in 2026, and our significantly lower expense base positions us to deliver additional profitable quarters, depending on revenue levels. We believe quarterly revenue of approximately $2.6 million to $2.7 million would bring us near our profitability threshold, beyond which incremental sales can drive meaningful improvements in operating performance. Combined with continued growth in our core dental business and CompuFlo® commercialization, we believe this operating leverage provides a foundation for sustainable growth and long-term shareholder value.”

Financial Results for the Three Months Ended September 30, 2026

For the three months ended September 30, 2026, total revenue was $2.2 million, compared to $2.4 million for the same period in 2025, representing a decrease of $140,000, or 5.9%. As expected, sales declined compared with the prior-year period, primarily reflecting lower dental product sales. The third quarter is typically a seasonally slower period, and the Company anticipated a moderation in revenue following the second quarter, which benefited from two large international orders. The impact of lower dental product sales was partially offset by growth in medical sales, as well as an increase in dental repair income.

Gross profit for the three months ended September 30, 2026 and 2025 was $1.6 million. Gross margin was 72.3% for the three months ended September 30, 2026 compared with 69.5% for the same period in 2025. The increase in gross margin was primarily due to lower product costs relative to sales during the current-year period.

Operating expenses decreased by $424,000, or 15.3%, to $2.4 million for the three months ended September 30, 2026, compared with $2.8 million for the three months ended September 30, 2025. The decrease was primarily attributable to lower salaries and compensation, stock-based compensation, professional fees and contract-related expenses, partially offset by increased marketing, regulatory, warehousing and travel expenses.

Net loss was $748,000, or ($0.01) per share, compared to a net loss of $1.2 million, or ($0.01) per share, in the prior year period.

Financial Results for the Nine Months Ended September 30, 2026

For the nine months ended September 30, 2026 and 2025, total revenue was $7.2 million and $6.9 million, respectively, an increase of $307,000, or 4.4%, driven by continued growth in international dental sales and higher recurring revenue from the Company’s medical segment.

Gross profit for the nine months ended September 30, 2026 and 2025 was $5.1 million and $4.9 million, or 70.3% and 70.9% of revenue, respectively.

Operating expenses decreased by $2.0 million, or 20.9%, to $7.5 million for the nine months ended September 30, 2026, compared with $9.5 million for the nine months ended September 30, 2025. The decrease was primarily attributable to lower professional fees, research and development, salaries and compensation, contract-related expenses, and quality control and regulatory expenses. These decreases were partially offset by higher warehousing and logistics, travel and marketing expenses. Expenses under an existing agreement decreased to approximately $91,000 from approximately $351,000 in the prior-year period, after the Company evaluated and optimized its contractual obligations.

Net loss for the nine months ended September 30, 2026 was $2.5 million, or $(0.03) per share, compared to a net loss of $4.6 million, or $(0.06) per share, for the comparable period in 2025.

As of September 30, 2026, the Company had cash and cash equivalents of $1.3 million, working capital of $3.5 million and $0 debt outstanding.

2026 Outlook

Management reaffirms its full-year 2026 revenue outlook of $9.8 million to $10.2 million, representing double-digit growth driven by continued expansion of commercial adoption across both the dental and medical segments. Revenue from the Company’s CompuFlo® medical business is expected to grow at a faster rate than overall Company revenue as it continues to expand physician engagement, strengthen reimbursement access and build its commercial infrastructure.

Management expects these initiatives, together with continued cost discipline and operating expense management, to support improved operating leverage and a meaningful reduction in cash burn compared with the prior year. The Company remains focused on increasing CompuFlo® adoption and utilization and growing recurring disposable revenue. Management expects the Company to approach or achieve profitability in the fourth quarter of 2026 and expects considerably lower losses in 2027 compared with 2026, with additional profitable quarters depending on revenue levels.

Conference Call

Milestone will host a conference call at 8:30 AM Eastern Time today, Friday, November 13, 2026, to discuss the company’s financial results for the third quarter ended September 30, 2026, as well as the company’s corporate progress and other developments.

The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or 973-528-0011 for international callers and by entering the access code: 612206. A live webcast and replay are available here: https://www.webcaster5.com/Webcast/Page/2306/54665.

An audio replay of the call will be available through November 25, 2026, and can be accessed by dialing 877-481-4010 for U.S. callers or 919-882-2331 for international callers and by entering the access code: 54665.

About Milestone Scientific Inc.

Milestone Scientific Inc. is a technology-focused medical research and development company that patents, designs, and develops innovative injection technologies and instruments for medical and dental applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the MLSS brand video or visit milestonescientific.com.

Safe Harbor Statement

This press release contains forward-looking statements regarding the timing and financial impact of Milestone’s ability to implement its business plan, expected revenues, timing of regulatory approvals and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions, future business decisions and regulatory developments, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone’s control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone’s periodic filings with the Securities and Exchange Commission, including without limitation, Milestone’s Annual Report for the year ended December 31, 2025. The forward-looking statements in this press release are based upon management’s reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

Contact:

HAYDEN IR:
James Carbonara
(646)-755-7412
james@haydenir.com

Brett Maas
(646) 536-7331
brett@haydenir.com

— Tables Follow –

MILESTONE SCIENTIFIC AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
		September 30, 2026				December 31, 2025
ASSETS
Current assets:
Cash and cash equivalents		$	1,315,401			$	1,112,642
Accounts receivable, net of allowance for credit losses of $10,000, respectively			1,087,584				680,620
Accounts receivable, related party			12,834				25,548
Other receivable			55,664				–
Prepaid expenses and other current assets			279,283				468,792
Inventories			2,735,323				3,781,837
Advances on contracts			1,279,102				1,408,395
Total current assets			6,765,191				7,477,834
Furniture, fixtures and equipment, net			18,795				19,193
Intangibles, net			27,754				79,063
Right of use assets finance lease			44,421				55,811
Right of use assets operating lease			62,433				150,378
Other assets			24,150				24,150
Total assets		$	6,942,744			$	7,806,429
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable		$	2,250,262			$	1,430,250
Accounts payable, related party			49,810				1,263,651
Accrued expenses and other payables			872,925				995,206
Accrued expenses, related party			–				88,799
Current portion of finance lease liabilities			37,587				27,347
Current portion of operating lease liabilities			68,927				130,355
Total current liabilities			3,279,511				3,935,608
Non-current portion of finance lease liabilities			6,834				27,336
Non-current portion of operating lease liabilities			–				35,208
Convertible notes payable, related parties			–				800,000
Total liabilities		$	3,286,345			$	4,798,152
Commitments and contingencies
Stockholders’ equity
Common stock, par value $0.001; authorized 135,000,000 shares; 90,644,403 shares issued and 90,611,070 shares outstanding as of September 30, 2026; 80,486,449 shares issued and 80,453,116 shares outstanding as of December 31, 2025;		$	90,645			$	80,487
Additional paid in capital			140,524,925				137,418,974
Accumulated deficit			(136,047,655	)			(133,579,668	)
Treasury stock, at cost, 33,333 shares			(911,516	)			(911,516	)
Total stockholders’ equity			3,656,399			$	3,008,277
Total liabilities and stockholders’ equity			6,942,744			$	7,806,429

MILESTONE SCIENTIFIC AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
		Three Months Ending				Three Months Ending				Nine Months Ending				Nine Months Ending
		September 30, 2026				September 30, 2025				September 30, 2026				September 30, 2025
Product sales, net		$	2,219,747			$	2,360,117			$	7,222,818			$	6,916,003
Cost of products sold			614,218				719,247				2,143,098				2,010,092
Gross profit			1,605,529				1,640,870				5,079,720				4,905,911
Selling, general and administrative expenses			2,321,312				2,739,011				7,474,552				9,026,691
Research and development expenses			10,413				16,226				3,222				437,135
Depreciation and amortization expense			20,096				20,104				59,139				59,040
Total operating expenses			2,351,821				2,775,341				7,536,913				9,522,866
Loss from operations			(746,292	)			(1,134,471	)			(2,457,193	)			(4,616,955	)
Interest (expense) income, net			(1,253	)			(19,488	)			(10,792	)			(14,700	)
Loss before provision for income taxes			(747,545	)			(1,153,959	)			(2,467,985	)			(4,631,655	)
Provision for income taxes			–				–				–				–
Net loss		$	(747,545	)		$	(1,153,959	)		$	(2,467,985	)		$	(4,631,655	)
Net loss per share applicable to common stockholders—
Basic and Diluted			(0.01	)			(0.01	)			(0.03	)			(0.06	)
Weighted average shares outstanding and to be issued—
Basic and diluted			93,913,021				82,049,984				90,151,697				81,903,323

Medical Segment Revenue Grows 136% Year-Over-Year

Expands CompuFlo® Physician Partnerships and Advances Medical Commercialization

Online Demonstrations More Than Double Reflecting Increased Customer Engagement

Reaffirms 2026 Outlook for Double-Digit Revenue Growth, Including Significant Growth in CompuFlo® Sales

Identifies approximately $400,000 in Additional Annual Savings, Supporting Expectation to Approach or Achieve Profitability in Fourth Quarter 2026 and Additional Profitable Quarters in 2027

ROSELAND, N.J., Nov. 13, 2026 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the three and nine months ended September 30, 2026.

Recent Business Highlights

• Identified cost-reduction initiatives expected to generate approximately $400,000 in additional annual savings, strengthening the Company’s path to potential profitability in Q4 2026 and additional profitable quarters in 2027.
• Expanded CompuFlo® clinical adoption across major healthcare organizations, highlighted by the initiation of clinical use at Rothman Orthopaedics, a nationally recognized orthopedic organization, and the addition of Pain and Spine Specialists, a 22-location Northeastern U.S. pain management network, and its medical director, Dr. Sudhir Rao, to the CompuFlo Advisor Program.
• Built a pipeline of more than 500 U.S. commercial leads, supported by five dedicated medical sales professionals, approximately 15 sales consultants and three distribution partners, with federal market access through Red One Medical.
• Reinforced CompuFlo’s clinical value proposition through a peer-reviewed 79-patient University of Texas Medical Branch study associating CompuFlo-guided epidural access with approximately 91% lower adjusted odds of composite complications compared with conventional loss-of-resistance techniques during spinal cord stimulator implantation.
• Highlighted substantial market potential across an estimated 30 million-plus annual epidural procedures worldwide, including more than 11 million in the U.S. Just 2% U.S. penetration could represent approximately $33 million in annual disposable revenue at $150 per procedure (illustrative only; not a revenue forecast).
• Submitted a provisional patent application for a potential new application of CompuFlo technology in intrathecal pump refills, extending its potential beyond epidural procedures.
• Strengthened international medical commercialization through distributor engagement and market development activities in Italy and Greece to support CompuFlo adoption and recurring sales.
• Pursued global strategic partnerships through go-to-market and licensing discussions with major medical technology organizations to expand international market reach.
• Broadened dental distribution opportunities through engagement with four potential distribution channels collectively serving thousands of dental offices.
• Achieved a debt-free balance sheet by eliminating outstanding director loans through a debt-to-equity conversion, supporting the Company’s focus on financial discipline.

“During the third quarter, we continued to advance our commercial strategy while maintaining disciplined expense management,” said Eric Hines, Chief Executive Officer of Milestone Scientific. “As anticipated, revenue moderated following the second quarter, which benefited from two large international orders. At the same time, we continued to build our commercial pipeline, with completed online demonstrations more than doubling during the first nine months of the year compared with the prior-year period. We believe this reflects growing customer engagement and the continued development of a more scalable sales process that can support future growth across our business. In dental, we are making progress with four potential distribution channels serving thousands of offices.

“In our medical business, we are gaining traction with major healthcare organizations, highlighted by the initiation of clinical use at Rothman Orthopaedics, a nationally recognized orthopedic organization with 34 locations, and the addition of Pain and Spine Specialists, a 22-location pain management network, to our CompuFlo® Advisor Program. These developments represent important milestones in expanding institutional engagement and physician adoption. We continue to strengthen reimbursement access, commercial infrastructure and clinical support to accelerate utilization and recurring disposable revenue with more than 500 U.S. commercial leads, our priority is converting that pipeline into active accounts and increasing procedure volumes. Internationally, we are seeing growing momentum in medical, and we are pursuing go-to-market and licensing initiatives with a few large medical technology organizations.

“Looking ahead, we expect to approach profitability, or be profitable, in the fourth quarter of 2026. Our team has remained focused on identifying cost-saving opportunities across the business, with initiatives expected to generate approximately $400,000 in additional annual savings, further strengthening our path to profitability. For 2027, we expect considerably lower losses than in 2026, and our significantly lower expense base positions us to deliver additional profitable quarters, depending on revenue levels. We believe quarterly revenue of approximately $2.6 million to $2.7 million would bring us near our profitability threshold, beyond which incremental sales can drive meaningful improvements in operating performance. Combined with continued growth in our core dental business and CompuFlo® commercialization, we believe this operating leverage provides a foundation for sustainable growth and long-term shareholder value.”

Financial Results for the Three Months Ended September 30, 2026

For the three months ended September 30, 2026, total revenue was $2.2 million, compared to $2.4 million for the same period in 2025, representing a decrease of $140,000, or 5.9%. As expected, sales declined compared with the prior-year period, primarily reflecting lower dental product sales. The third quarter is typically a seasonally slower period, and the Company anticipated a moderation in revenue following the second quarter, which benefited from two large international orders. The impact of lower dental product sales was partially offset by growth in medical sales, as well as an increase in dental repair income.

Gross profit for the three months ended September 30, 2026 and 2025 was $1.6 million. Gross margin was 72.3% for the three months ended September 30, 2026 compared with 69.5% for the same period in 2025. The increase in gross margin was primarily due to lower product costs relative to sales during the current-year period.

Operating expenses decreased by $424,000, or 15.3%, to $2.4 million for the three months ended September 30, 2026, compared with $2.8 million for the three months ended September 30, 2025. The decrease was primarily attributable to lower salaries and compensation, stock-based compensation, professional fees and contract-related expenses, partially offset by increased marketing, regulatory, warehousing and travel expenses.

Net loss was $748,000, or ($0.01) per share, compared to a net loss of $1.2 million, or ($0.01) per share, in the prior year period.

Financial Results for the Nine Months Ended September 30, 2026

For the nine months ended September 30, 2026 and 2025, total revenue was $7.2 million and $6.9 million, respectively, an increase of $307,000, or 4.4%, driven by continued growth in international dental sales and higher recurring revenue from the Company’s medical segment.

Gross profit for the nine months ended September 30, 2026 and 2025 was $5.1 million and $4.9 million, or 70.3% and 70.9% of revenue, respectively.

Operating expenses decreased by $2.0 million, or 20.9%, to $7.5 million for the nine months ended September 30, 2026, compared with $9.5 million for the nine months ended September 30, 2025. The decrease was primarily attributable to lower professional fees, research and development, salaries and compensation, contract-related expenses, and quality control and regulatory expenses. These decreases were partially offset by higher warehousing and logistics, travel and marketing expenses. Expenses under an existing agreement decreased to approximately $91,000 from approximately $351,000 in the prior-year period, after the Company evaluated and optimized its contractual obligations.

Net loss for the nine months ended September 30, 2026 was $2.5 million, or $(0.03) per share, compared to a net loss of $4.6 million, or $(0.06) per share, for the comparable period in 2025.

As of September 30, 2026, the Company had cash and cash equivalents of $1.3 million, working capital of $3.5 million and $0 debt outstanding.

2026 Outlook

Management reaffirms its full-year 2026 revenue outlook of $9.8 million to $10.2 million, representing double-digit growth driven by continued expansion of commercial adoption across both the dental and medical segments. Revenue from the Company’s CompuFlo® medical business is expected to grow at a faster rate than overall Company revenue as it continues to expand physician engagement, strengthen reimbursement access and build its commercial infrastructure.

Management expects these initiatives, together with continued cost discipline and operating expense management, to support improved operating leverage and a meaningful reduction in cash burn compared with the prior year. The Company remains focused on increasing CompuFlo® adoption and utilization and growing recurring disposable revenue. Management expects the Company to approach or achieve profitability in the fourth quarter of 2026 and expects considerably lower losses in 2027 compared with 2026, with additional profitable quarters depending on revenue levels.

Conference Call

Milestone will host a conference call at 8:30 AM Eastern Time today, Friday, November 13, 2026, to discuss the company’s financial results for the third quarter ended September 30, 2026, as well as the company’s corporate progress and other developments.

The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or 973-528-0011 for international callers and by entering the access code: 612206. A live webcast and replay are available here: https://www.webcaster5.com/Webcast/Page/2306/54665.

An audio replay of the call will be available through November 25, 2026, and can be accessed by dialing 877-481-4010 for U.S. callers or 919-882-2331 for international callers and by entering the access code: 54665.

About Milestone Scientific Inc.

Milestone Scientific Inc. is a technology-focused medical research and development company that patents, designs, and develops innovative injection technologies and instruments for medical and dental applications. Milestone Scientific’s computer-controlled systems are designed to make injections precise, efficient and increase the overall patient comfort and safety. Their proprietary DPS Dynamic Pressure Sensing Technology® instruments is the platform to advance the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions of subcutaneous drug delivery, including local anesthetic. To learn more, view the MLSS brand video or visit milestonescientific.com.

Safe Harbor Statement

This press release contains forward-looking statements regarding the timing and financial impact of Milestone’s ability to implement its business plan, expected revenues, timing of regulatory approvals and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions, future business decisions and regulatory developments, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone’s control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone’s periodic filings with the Securities and Exchange Commission, including without limitation, Milestone’s Annual Report for the year ended December 31, 2025. The forward-looking statements in this press release are based upon management’s reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

Contact:

HAYDEN IR:
James Carbonara
(646)-755-7412
james@haydenir.com

Brett Maas
(646) 536-7331
brett@haydenir.com

— Tables Follow –

MILESTONE SCIENTIFIC AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
		September 30, 2026				December 31, 2025
ASSETS
Current assets:
Cash and cash equivalents		$	1,315,401			$	1,112,642
Accounts receivable, net of allowance for credit losses of $10,000, respectively			1,087,584				680,620
Accounts receivable, related party			12,834				25,548
Other receivable			55,664				–
Prepaid expenses and other current assets			279,283				468,792
Inventories			2,735,323				3,781,837
Advances on contracts			1,279,102				1,408,395
Total current assets			6,765,191				7,477,834
Furniture, fixtures and equipment, net			18,795				19,193
Intangibles, net			27,754				79,063
Right of use assets finance lease			44,421				55,811
Right of use assets operating lease			62,433				150,378
Other assets			24,150				24,150
Total assets		$	6,942,744			$	7,806,429
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable		$	2,250,262			$	1,430,250
Accounts payable, related party			49,810				1,263,651
Accrued expenses and other payables			872,925				995,206
Accrued expenses, related party			–				88,799
Current portion of finance lease liabilities			37,587				27,347
Current portion of operating lease liabilities			68,927				130,355
Total current liabilities			3,279,511				3,935,608
Non-current portion of finance lease liabilities			6,834				27,336
Non-current portion of operating lease liabilities			–				35,208
Convertible notes payable, related parties			–				800,000
Total liabilities		$	3,286,345			$	4,798,152
Commitments and contingencies
Stockholders’ equity
Common stock, par value $0.001; authorized 135,000,000 shares; 90,644,403 shares issued and 90,611,070 shares outstanding as of September 30, 2026; 80,486,449 shares issued and 80,453,116 shares outstanding as of December 31, 2025;		$	90,645			$	80,487
Additional paid in capital			140,524,925				137,418,974
Accumulated deficit			(136,047,655	)			(133,579,668	)
Treasury stock, at cost, 33,333 shares			(911,516	)			(911,516	)
Total stockholders’ equity			3,656,399			$	3,008,277
Total liabilities and stockholders’ equity			6,942,744			$	7,806,429

MILESTONE SCIENTIFIC AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
		Three Months Ending				Three Months Ending				Nine Months Ending				Nine Months Ending
		September 30, 2026				September 30, 2025				September 30, 2026				September 30, 2025
Product sales, net		$	2,219,747			$	2,360,117			$	7,222,818			$	6,916,003
Cost of products sold			614,218				719,247				2,143,098				2,010,092
Gross profit			1,605,529				1,640,870				5,079,720				4,905,911
Selling, general and administrative expenses			2,321,312				2,739,011				7,474,552				9,026,691
Research and development expenses			10,413				16,226				3,222				437,135
Depreciation and amortization expense			20,096				20,104				59,139				59,040
Total operating expenses			2,351,821				2,775,341				7,536,913				9,522,866
Loss from operations			(746,292	)			(1,134,471	)			(2,457,193	)			(4,616,955	)
Interest (expense) income, net			(1,253	)			(19,488	)			(10,792	)			(14,700	)
Loss before provision for income taxes			(747,545	)			(1,153,959	)			(2,467,985	)			(4,631,655	)
Provision for income taxes			–				–				–				–
Net loss		$	(747,545	)		$	(1,153,959	)		$	(2,467,985	)		$	(4,631,655	)
Net loss per share applicable to common stockholders—
Basic and Diluted			(0.01	)			(0.01	)			(0.03	)			(0.06	)
Weighted average shares outstanding and to be issued—
Basic and diluted			93,913,021				82,049,984				90,151,697				81,903,323

WINTER PARK, Fla., Nov. 13, 2026 (GLOBE NEWSWIRE) — Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a technology company building the future of the commodity markets through tokenization, today announced that its independent registered public accounting firm has completed additional independent monthly examinations of the reserves backing GLDY, the Company’s gold-backed, yield-bearing tokenized security. The examination covers gold in reserve and gold on lease between April 1 and September 30, 2026, and marks the continuation of monthly reporting Streamex intends to conduct on an ongoing basis.

• GLDY tokens are subject to an independent examination on management’s assertion that each GLDY token is backed by at least one troy ounce of gold. Our independent registered public accounting firm’s reports have been made publicly available at https://ir.streamex.com/reserve-reports-gldy-0. Investors are encouraged to read these reports in their entirety.
   
• This is a continuation of monthly examinations, conducted on a monthly basis. Streamex is committed to making the results of these independent reserve examinations publicly available upon completion. These monthly examinations are in addition to a year-end audit giving investors additional confidence that GLDY tokens are backed by at least one troy ounce of gold.

Attestation Details

Under the engagement, our registered public accounting firm performs an examination, conducted in accordance with the attestation standards established by the American Institute of Certified Public Accountants (AICPA), of management’s assertion regarding the gold held for the benefit of GLDY token holders. The examination evaluates management’s assertion that, as of each report date, the total redemption assets held, measured in fine troy ounces of gold, are equal to or greater than the total GLDY redeemable tokens outstanding.

The reserve position reflects gold held in approved vaults for the benefit of token holders together with gold deployed under the Company’s leasing program with Monetary Metals, in which the Company retains title to the leased gold throughout the lease term. An examination provides reasonable assurance and results in the expression of an independent opinion on management’s assertion.

Streamex makes each completed attestation available to investors as part of its broader commitment to independent, third-party attestation of GLDY’s reserves. All monthly attestations completed to date can be viewed here: https://ir.streamex.com/reserve-reports-gldy-0.

The following summarizes the results of the April through September 2026 examinations:

GLDY Reserve Attestation Summary	Apr 30, 2026	May 31, 2026	Jun 30, 2026	Jul 31, 2026	Aug 31, 2026	Sep 30, 2026
Examination standard	AICPA attestation standards (SSAE)
GLDY redeemable tokens outstanding	3,077.727598	3,102.101064	3,111.047523	3,133.439783	3,143.867870	3,350.519190
Total redemption assets (fine troy oz of gold)	3,077.727601	3,102.103500	3,111.050240	3,133.442324	3,143.868516	3,350.520232
Surplus (deficit)	0.000003	0.002436	0.002717	0.002541	0.000646	0.001042
Asset-backing coverage	≥ 100%	≥ 100%	≥ 100%	≥ 100%	≥ 100%	≥ 100%
Examiner’s opinion	Unmodified	Unmodified	Unmodified	Unmodified	Unmodified	Unmodified

Note: Figures are presented as of each report date and are subject to the scope, criteria, and limitations described in the independent accountants’ examination reports. The examinations address management’s reserve assertion and are separate from the Company’s annual audited financial statements.

Henry McPhie, Co-Founder & Chief Executive Officer of Streamex, said:

“Independent assurance is the foundation of institutional trust. Our continual third-party reserve attestations confirm that the gold backing every GLDY token is real, accounted for, and verifiable, not just on-chain.”

Ongoing Transparency

GLDY is a gold-backed, yield-bearing tokenized security that pays a 3.5% target yield in additional gold through gold leasing. Investors can view real-time GLDY data, including NAV and reserves, at https://app.rwa.xyz/assets/GLDY and via the Chainlink Proof of Reserves Oracle at https://data.chain.link/feeds/base/base/gldy-reserves. GLDY is available for purchase at app.streamex.com.

About Streamex Corp.

Streamex Corp. (NASDAQ: STEX) is a technology and infrastructure company focused on the tokenization and digitalization of commodity real-world assets. Streamex delivers institutional-grade solutions that bridge traditional finance and blockchain-enabled markets through secure, regulated, and yield-bearing financial instruments.

For more information, visit www.streamex.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Streamex’s business strategy, future growth, product development, the cadence and results of reserve attestations, and the expected performance of GLDY. These statements are based on current expectations and assumptions that are subject to risks and uncertainties, many of which are beyond Streamex’s control, and actual results may differ materially. Factors that could cause such differences include, among others, market conditions, regulatory developments, and macroeconomic factors affecting digital asset markets. A discussion of these and other factors is set forth in Streamex’s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K, as may be supplemented or updated by Streamex’s Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Streamex undertakes no obligation to update or revise any forward-looking statements except as required by applicable law.

Contacts

Streamex Press & Investor Relations
Laura Kiernan	Henry McPhie
Head of Investor Relations, Streamex Corp.	Chief Executive Officer, Streamex Corp.
IR@streamex.com | 1-914-598-7733	www.streamex.com | X.com/streamex

WINTER PARK, Fla., Nov. 13, 2026 (GLOBE NEWSWIRE) — Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a technology company building the future of the commodity markets through tokenization, today announced that its independent registered public accounting firm has completed additional independent monthly examinations of the reserves backing GLDY, the Company’s gold-backed, yield-bearing tokenized security. The examination covers gold in reserve and gold on lease between April 1 and September 30, 2026, and marks the continuation of monthly reporting Streamex intends to conduct on an ongoing basis.

• GLDY tokens are subject to an independent examination on management’s assertion that each GLDY token is backed by at least one troy ounce of gold. Our independent registered public accounting firm’s reports have been made publicly available at https://ir.streamex.com/reserve-reports-gldy-0. Investors are encouraged to read these reports in their entirety.
   
• This is a continuation of monthly examinations, conducted on a monthly basis. Streamex is committed to making the results of these independent reserve examinations publicly available upon completion. These monthly examinations are in addition to a year-end audit giving investors additional confidence that GLDY tokens are backed by at least one troy ounce of gold.

Attestation Details

Under the engagement, our registered public accounting firm performs an examination, conducted in accordance with the attestation standards established by the American Institute of Certified Public Accountants (AICPA), of management’s assertion regarding the gold held for the benefit of GLDY token holders. The examination evaluates management’s assertion that, as of each report date, the total redemption assets held, measured in fine troy ounces of gold, are equal to or greater than the total GLDY redeemable tokens outstanding.

The reserve position reflects gold held in approved vaults for the benefit of token holders together with gold deployed under the Company’s leasing program with Monetary Metals, in which the Company retains title to the leased gold throughout the lease term. An examination provides reasonable assurance and results in the expression of an independent opinion on management’s assertion.

Streamex makes each completed attestation available to investors as part of its broader commitment to independent, third-party attestation of GLDY’s reserves. All monthly attestations completed to date can be viewed here: https://ir.streamex.com/reserve-reports-gldy-0.

The following summarizes the results of the April through September 2026 examinations:

GLDY Reserve Attestation Summary	Apr 30, 2026	May 31, 2026	Jun 30, 2026	Jul 31, 2026	Aug 31, 2026	Sep 30, 2026
Examination standard	AICPA attestation standards (SSAE)
GLDY redeemable tokens outstanding	3,077.727598	3,102.101064	3,111.047523	3,133.439783	3,143.867870	3,350.519190
Total redemption assets (fine troy oz of gold)	3,077.727601	3,102.103500	3,111.050240	3,133.442324	3,143.868516	3,350.520232
Surplus (deficit)	0.000003	0.002436	0.002717	0.002541	0.000646	0.001042
Asset-backing coverage	≥ 100%	≥ 100%	≥ 100%	≥ 100%	≥ 100%	≥ 100%
Examiner’s opinion	Unmodified	Unmodified	Unmodified	Unmodified	Unmodified	Unmodified

Note: Figures are presented as of each report date and are subject to the scope, criteria, and limitations described in the independent accountants’ examination reports. The examinations address management’s reserve assertion and are separate from the Company’s annual audited financial statements.

Henry McPhie, Co-Founder & Chief Executive Officer of Streamex, said:

“Independent assurance is the foundation of institutional trust. Our continual third-party reserve attestations confirm that the gold backing every GLDY token is real, accounted for, and verifiable, not just on-chain.”

Ongoing Transparency

GLDY is a gold-backed, yield-bearing tokenized security that pays a 3.5% target yield in additional gold through gold leasing. Investors can view real-time GLDY data, including NAV and reserves, at https://app.rwa.xyz/assets/GLDY and via the Chainlink Proof of Reserves Oracle at https://data.chain.link/feeds/base/base/gldy-reserves. GLDY is available for purchase at app.streamex.com.

About Streamex Corp.

Streamex Corp. (NASDAQ: STEX) is a technology and infrastructure company focused on the tokenization and digitalization of commodity real-world assets. Streamex delivers institutional-grade solutions that bridge traditional finance and blockchain-enabled markets through secure, regulated, and yield-bearing financial instruments.

For more information, visit www.streamex.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Streamex’s business strategy, future growth, product development, the cadence and results of reserve attestations, and the expected performance of GLDY. These statements are based on current expectations and assumptions that are subject to risks and uncertainties, many of which are beyond Streamex’s control, and actual results may differ materially. Factors that could cause such differences include, among others, market conditions, regulatory developments, and macroeconomic factors affecting digital asset markets. A discussion of these and other factors is set forth in Streamex’s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K, as may be supplemented or updated by Streamex’s Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Streamex undertakes no obligation to update or revise any forward-looking statements except as required by applicable law.

Contacts

Streamex Press & Investor Relations
Laura Kiernan	Henry McPhie
Head of Investor Relations, Streamex Corp.	Chief Executive Officer, Streamex Corp.
IR@streamex.com | 1-914-598-7733	www.streamex.com | X.com/streamex

OSB GROUP PLC announces Final Results of its Tender Offers for its
£300,000,000 Fixed Rate Resetting Notes due 7 September 2028 and £400,000,000 Fixed Rate Resetting Notes due 16 January 2030

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (the EUWA).

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT, OR TO ANY ADDRESS, IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OF AMERICA OR THE DISTRICT OF COLUMBIA (the United States) OR IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE OR TO WHOM IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

13 November 2026. OSB GROUP PLC (the Offeror) announces today the final results of its separate invitations to holders of its outstanding: (i) £300,000,000 Fixed Rate Resetting Notes due 7 September 2028 (ISIN: XS2642668821) (the 2028 Notes); and (ii) £400,000,000 Fixed Rate Resetting Notes due 16 January 2030 (ISIN: XS2747270986) (the 2030 Notes and, together with the 2028 Notes, the Notes and each a Series) to tender their Notes for purchase by the Offeror for cash (each such invitation, an Offer, and together, the Offers).

The Offers were announced on 5 November 2026 and were made on the terms and subject to the conditions contained in the tender offer memorandum dated 5 November 2026 (the Tender Offer Memorandum) prepared by the Offeror in connection with the Offers. Capitalised terms used but not otherwise defined in this announcement shall have the meanings given to them in the Tender Offer Memorandum.

Expiration Deadline

The Expiration Deadline for the Offers was 4.00 p.m. (London time) on 12 November 2026. As at the Expiration Deadline, the Offeror had received valid tenders for purchase pursuant to the Offers of (i) £279,585,000 in aggregate principal amount of the 2028 Notes; and (ii) £354,849,000 in aggregate principal amount of the 2030 Notes.

Final Acceptance Amount

The Offeror confirms that the Final Acceptance Amount is £634,434,000, to be allocated between the 2028 Notes and the 2030 Notes as set out below.

Results of the Offers

The Offeror will accept, (i) the 2028 Notes validly tendered pursuant to the relevant Offer in full, with no pro-rata scaling; and (ii) the 2030 Notes validly tendered pursuant to the relevant Offer in full, with no pro-rata scaling.

Pricing for the Offers took place at around 11.00 a.m. (London time) (the Pricing Time) today. The Offeror determined that the Purchase Price it will pay for the Notes validly tendered and accepted for purchase pursuant to each Offer will be: (i) in respect of the 2028 Notes, 103.369 per cent. of the principal amount of such 2028 Notes; and (ii) in respect of the 2030 Notes, 106.083 per cent. of the principal amount of such 2030 Notes, in each case based on a Settlement Date of 16 November 2026, and together with an Accrued Interest Payment.

A summary of the final results of, and pricing for, the Offers is set out below:

Notes		Series Acceptance Amount	Scaling Factor	Relevant Benchmark Security Rate	Purchase Spread	Purchase Yield	Purchase Price*
2028 Notes		£279,585,000	Not Applicable	4.364 per cent.	80 bps	5.164 per cent.	103.369 per cent.
2030 Notes		£354,849,000	Not Applicable	4.787 per cent.	105 bps	5.837 per cent.	106.083 per cent.
*	Expressed as a percentage of the aggregate principal amount of the relevant Notes.

General

The Settlement Date in respect of the Notes accepted for purchase pursuant to the Offers is expected to be 16 November 2026. Following settlement for the Offers, (i) £20,415,000 in aggregate principal amount of the 2028 Notes will remain outstanding; and (ii) £45,151,000 in aggregate principal amount of the 2030 Notes will remain outstanding.

Jefferies International Limited (Attention: Liability Management EMEA; Telephone: +44 20 7029 8000; Email: liabilitymanagement@jefferies.com) and Morgan Stanley & Co. International plc (Attention: Liability Management Team, Global Capital Markest; Telephone: +44 20 7425 5695; Email: liabilitymanagementeurope@morganstanley.com) and Kroll Issuer Services Limited (Attention: Owen Morris; Telephone: +44 20 7704 0880; Email: osb@is.kroll.com).

1. Offeror Legal Entity Identifier (LEI): 213800ZBKL9BHSL2K459
2. This announcement is released by the Offeror and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the EUWA (UK MAR), encompassing information relating to the Offers described above. For the purposes of UK MAR and the Implementing Technical Standards, this announcement is made by Jason Elphick, Group General Counsel and Company Secretary.

DISCLAIMER The offer period for the Offers has now expired. No further tenders of Notes may be made pursuant to the Offers. This announcement must be read in conjunction with the Tender Offer Memorandum. No offer or invitation to acquire any securities is being made pursuant to this announcement. The distribution of this announcement, the Tender Offer Memorandum and/or any other materials relating to the Offers in certain jurisdictions may be restricted by law. Persons into whose possession this announcement, the Tender Offer Memorandum and/or any other materials relating to the Offers come are required by each of the Offeror, the Dealer Managers and the Tender Agent to inform themselves about, and to observe, any such restrictions.

OSB GROUP PLC announces Final Results of its Tender Offers for its
£300,000,000 Fixed Rate Resetting Notes due 7 September 2028 and £400,000,000 Fixed Rate Resetting Notes due 16 January 2030

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (the EUWA).

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT, OR TO ANY ADDRESS, IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OF AMERICA OR THE DISTRICT OF COLUMBIA (the United States) OR IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE OR TO WHOM IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

13 November 2026. OSB GROUP PLC (the Offeror) announces today the final results of its separate invitations to holders of its outstanding: (i) £300,000,000 Fixed Rate Resetting Notes due 7 September 2028 (ISIN: XS2642668821) (the 2028 Notes); and (ii) £400,000,000 Fixed Rate Resetting Notes due 16 January 2030 (ISIN: XS2747270986) (the 2030 Notes and, together with the 2028 Notes, the Notes and each a Series) to tender their Notes for purchase by the Offeror for cash (each such invitation, an Offer, and together, the Offers).

The Offers were announced on 5 November 2026 and were made on the terms and subject to the conditions contained in the tender offer memorandum dated 5 November 2026 (the Tender Offer Memorandum) prepared by the Offeror in connection with the Offers. Capitalised terms used but not otherwise defined in this announcement shall have the meanings given to them in the Tender Offer Memorandum.

Expiration Deadline

The Expiration Deadline for the Offers was 4.00 p.m. (London time) on 12 November 2026. As at the Expiration Deadline, the Offeror had received valid tenders for purchase pursuant to the Offers of (i) £279,585,000 in aggregate principal amount of the 2028 Notes; and (ii) £354,849,000 in aggregate principal amount of the 2030 Notes.

Final Acceptance Amount

The Offeror confirms that the Final Acceptance Amount is £634,434,000, to be allocated between the 2028 Notes and the 2030 Notes as set out below.

Results of the Offers

The Offeror will accept, (i) the 2028 Notes validly tendered pursuant to the relevant Offer in full, with no pro-rata scaling; and (ii) the 2030 Notes validly tendered pursuant to the relevant Offer in full, with no pro-rata scaling.

Pricing for the Offers took place at around 11.00 a.m. (London time) (the Pricing Time) today. The Offeror determined that the Purchase Price it will pay for the Notes validly tendered and accepted for purchase pursuant to each Offer will be: (i) in respect of the 2028 Notes, 103.369 per cent. of the principal amount of such 2028 Notes; and (ii) in respect of the 2030 Notes, 106.083 per cent. of the principal amount of such 2030 Notes, in each case based on a Settlement Date of 16 November 2026, and together with an Accrued Interest Payment.

A summary of the final results of, and pricing for, the Offers is set out below:

Notes		Series Acceptance Amount	Scaling Factor	Relevant Benchmark Security Rate	Purchase Spread	Purchase Yield	Purchase Price*
2028 Notes		£279,585,000	Not Applicable	4.364 per cent.	80 bps	5.164 per cent.	103.369 per cent.
2030 Notes		£354,849,000	Not Applicable	4.787 per cent.	105 bps	5.837 per cent.	106.083 per cent.
*	Expressed as a percentage of the aggregate principal amount of the relevant Notes.

General

The Settlement Date in respect of the Notes accepted for purchase pursuant to the Offers is expected to be 16 November 2026. Following settlement for the Offers, (i) £20,415,000 in aggregate principal amount of the 2028 Notes will remain outstanding; and (ii) £45,151,000 in aggregate principal amount of the 2030 Notes will remain outstanding.

Jefferies International Limited (Attention: Liability Management EMEA; Telephone: +44 20 7029 8000; Email: liabilitymanagement@jefferies.com) and Morgan Stanley & Co. International plc (Attention: Liability Management Team, Global Capital Markest; Telephone: +44 20 7425 5695; Email: liabilitymanagementeurope@morganstanley.com) and Kroll Issuer Services Limited (Attention: Owen Morris; Telephone: +44 20 7704 0880; Email: osb@is.kroll.com).

1. Offeror Legal Entity Identifier (LEI): 213800ZBKL9BHSL2K459
2. This announcement is released by the Offeror and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the EUWA (UK MAR), encompassing information relating to the Offers described above. For the purposes of UK MAR and the Implementing Technical Standards, this announcement is made by Jason Elphick, Group General Counsel and Company Secretary.

DISCLAIMER The offer period for the Offers has now expired. No further tenders of Notes may be made pursuant to the Offers. This announcement must be read in conjunction with the Tender Offer Memorandum. No offer or invitation to acquire any securities is being made pursuant to this announcement. The distribution of this announcement, the Tender Offer Memorandum and/or any other materials relating to the Offers in certain jurisdictions may be restricted by law. Persons into whose possession this announcement, the Tender Offer Memorandum and/or any other materials relating to the Offers come are required by each of the Offeror, the Dealer Managers and the Tender Agent to inform themselves about, and to observe, any such restrictions.